Truelab Biopharmaceutical Co., Ltd

This early-stage trial is testing a new drug, TL-003, for the first time in humans. The main goal is to check its safety and how the body processes it in 48 healthy adults, with a small group of people who have ulcerative colitis also being studied. Researchers will monitor for s…